![Lars Abrahmsén](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Abrahmsén
Technik-/Wissenschafts-/F&E-Leiter bei
Akinion Pharmaceuticals AB
Profil
Lars Abrahmsén is currently working as CSO & VP-Preclinical Development at Akinion Pharmaceuticals AB and KDev Oncology AB. He previously worked as Principal at Genentech, Inc., Senior Project Team Leader at Pharmacia & Upjohn, Inc., Chief Scientific Officer at Affibody AB, Senior Project Team Leader at Biovitrum AB, Senior Vice President-Protein Therapeutics at Algeta ASA, CSO & VP-Preclinical Development at Axelar AB, and Principal at Kabi Pharmacia.
He completed his graduate and doctorate degrees from the Royal Institute of Technology.
Aktive Positionen von Lars Abrahmsén
| Unternehmen | Position | Beginn |
|---|---|---|
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Technik-/Wissenschafts-/F&E-Leiter | - |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Lars Abrahmsén
| Unternehmen | Position | Ende |
|---|---|---|
| APREA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.08.2022 |
| ALGETA ASA | Corporate Officer/Principal | 01.01.2013 |
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lars Abrahmsén
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Kabi Pharmacia | |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
